The acute respiratory distress syndrome (ARDS), a process of non-hydrostatic pulmonary
edema and hypoxemia with a variety of etiologies, consists of diffuse, acute parenchymal …

As reported in Chapter 2, despite a number of important advances in mechanical ventilatory
support, intensive care unit technology, and critical care training, the mortality due to …

The pathogenesis of the acute respiratory distress syndrome (ARDS) remains incompletely
understood. It is generally believed that extrapulmonary factors, such as sepsis and trauma …

A characteristic feature of all inflammatory disorders is the excessive recruitment of
leukocytes to the site of inflammation. The loss of control in trafficking these cells contributes …

The acute respiratory distress syndrome (ARDS) causes 40% mortality in approximately
200,000 critically ill patients annually in the United States. ARDS is caused by protein-rich …

Clinicians throughout the world continue to be challenged with the task of caring for patients
with acute lung injury. Although recognised as early as the mid-1940s as 'traumatic wet …

Abstract Acute Respiratory Distress Syndrome (ARDS) is a severe lung inflammatory
disorder with a 30–50% mortality. Sepsis and pneumonia are the leading causes of ARDS …

Among the many groups of mediators involved in the pathogenesis and clinical expression
of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), cytokines occupy …

Important advances have been made in our understanding of acute respiratory distress
syndrome (ARDS) pathophysiology, largely as the result of mechanistic studies about the …

Inflammatory response leading to organ dysfunction and failure continues to be the major
problem after injury in many clinical conditions such as sepsis, severe burns, acute …